Abstract
Blastoschizomyces capitatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eight-fold more active than amphotericin B and ketoconazole against all isolates but one.
Original language | English |
---|---|
Pages (from-to) | 13-15 |
Number of pages | 3 |
Journal | Journal of Chemotherapy |
Volume | 3 |
DOIs | |
Publication status | Published - 1991 |
Keywords
- Antifungal Agents
- Fluconazole
- Geotrichum
- Microbial Sensitivity Tests
- Mitosporic Fungi
- Trichosporon